Key Highlights

  • FY26 Revenue of $19.8M, up 0.3% on prior corresponding period, with gross margins sustained at 75%
  • Operating EBITDA loss of $0.6M compared to a loss of $0.2M in the prior period amid higher R&D and Marketing spend
  • North America revenue declined 29% due to US government regulatory disruption and NIOSH suspension
  • Board announced a 10% on-market share buyback and launched new AGILE respirator product

CleanSpace Holdings Limited(ASX:CSX), an Australian company that designs, manufactures and sells powered air-purifying respiratory protection solutions, has released its audited financial results for the financial year ended 30 June 2026 (FY26). The company reported total revenue of $19.8 million, up 0.3% on the prior corresponding period, while recording an operating EBITDA loss of $0.6 million.

Revenue and Regional Performance

Group revenue for FY26 was $19.8 million, essentially flat year-on-year. Europe contributed 65% of total revenue at $12.9 million, rising 8% on FY25. France, the company's largest market, continued its growth trajectory through repeat distributor business. The Nordic Business also contributed to European growth, partially offsetting regulatory headwinds in the UK and softness in the DACH region.

Asia Pacific and Rest of World revenue was $4.7 million, flat versus FY25. Southeast Asia grew 76% despite disruptions from a landslide at a major Indonesian mine. North America contributed $2.2 million, down 29%, which the company attributed to US government intervention including the suspension of the National Institute for Occupational Safety and Health (NIOSH) and a delay to the Mining Safety and Health Administration silica dust rule.

Margins and Cost Management

Gross margins were sustained at 75%, consistent with the prior period, through disciplined cost management that offset inflationary pressures. Operating expenses rose 3% to $15.4 million, reflecting increased Investment in Research and Development, up 19%, and Sales and Marketing, up 39%, ahead of new product launches and systems upgrades. Cash at bank was $10.1 million at year end, down $0.4 million from FY25.

Product Launch and Strategic Developments

During FY26, CleanSpace launched AGILE, a loose-fitting powered air-purifying respirator designed to open new opportunities in sectors including mining and infrastructure. The product received European certification in early June, with new sales realised within 24 hours. AGILE was also certified in Australia and New Zealand ten days before the financial year end. Respirator sales represented 54% of group revenue in FY26, up from 53% in FY25.

Buyback and Outlook

The Board announced a 10% on-market share buyback, stating its view that CleanSpace shares are undervalued at current price levels. CEO Gabrielle O'Carroll noted that FY26 was a year of deliberate investment in capabilities intended to underpin the company's next phase of growth.